Bon TEV
Di bawah adalah senarai bon-bon korporat TEVA PHARMACEUT. SP.ADR. Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol | YTM % | Volum | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA5034099Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 7.40% | 500 K | 99.73% | 7.13% | 2025-01-31 | 425.259 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 7.00% | 1 M | 99.25% | 6.75% | 2028-03-01 | 255 K USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTEVA P.FI.NL III 16/46 | 6.35% | 0 | 70.92% | 4.10% | 2046-10-01 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 6.15% | 50 K | 111.15% | 8.13% | 2031-09-15 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6.15% | 1.2 M | 101.79% | 6.75% | 2028-03-01 | 1.25 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD1TEVA PHARM.FIN. 2036 | 6.15% | 0 | 100.03% | 6.15% | 2036-02-01 | 789.428 M USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 6.04% | 200 K | 107.73% | 7.88% | 2029-09-15 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | 5.98% | 500 K | 96.62% | 5.13% | 2029-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFABTEVA P.FI.NL III 16/26 | 5.91% | 0 | 95.11% | 3.15% | 2026-10-01 | 3.378 B USD | 1,000.00 USD | 2,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | 5.91% | 190 K | 97.34% | 4.75% | 2027-05-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS219821395TEVA PHARM FINANCE NL II 6% GTD SNR NTS 31/01/2025 EUR100000 | 5.89% | 0 | 100.11% | 6.00% | 2025-01-31 | 410.607 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA4914602Teva Pharmaceutical Finance Netherlands III BV 7.125% 31-JAN-2025 | 5.84% | 0 | 101.25% | 7.13% | 2025-01-31 | 1.255 M USD | 1,000.00 USD | 200,000.00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4.55% | 0 | 119.66% | 7.88% | 2031-09-15 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS181372460TEVA PH.F.NL.II 18/25 | 4.50% | 0 | 100.00% | 4.50% | 2025-03-01 | 494.346 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 4.33% | 0 | 113.31% | 7.38% | 2029-09-15 | 800 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 4.29% | 0 | 100.40% | 4.38% | 2030-05-09 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3.89% | 0 | 99.68% | 3.75% | 2027-05-09 | 1.1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS121104407TEVA PH.F.NL.II 15/27 | 3.81% | 0 | 95.61% | 1.88% | 2027-03-31 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS143974936TEVA PH.F.NL.II 16/28 | 3.71% | 0 | 92.40% | 1.63% | 2028-10-15 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 2.77% | 430 K | 97.00% | 0.25% | 2026-02-01 | 22.879 M USD | 1,000.00 USD | 1,000.00 USD | Teva Pharmaceutical Finance Co. LLC |
| CCH33382750TEVA PH.FI.NL IV 16-25 | 2.01% | 5 K | 99.00% | 1.00% | 2025-07-28 | 350 M CHF | 5,000.00 CHF | 5,000.00 CHF | — |
| TTEVA3666246IVAX LLC 1.875% 15-DEC-2024 | — | — | — | 1.88% | 2024-12-15 | 333 M USD | 1,000.00 USD | 1,000.00 USD | IVAX LLC |